Cargando…
Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture
SIMPLE SUMMARY: Approximately 50% of patients with uveal melanoma will develop incurable metastatic disease. This can be predicted, but requires a biopsy of the eye, which outside of centres of excellence, are not routinely performed. Given that uveal melanoma spreads through the blood, utilising ci...
Autores principales: | Beasley, Aaron B., Isaacs, Timothy W., Vermeulen, Tersia, Freeman, James, DeSousa, Jean-Louis, Bhikoo, Riyaz, Hennessy, Doireann, Reid, Anna, Chen, Fred K., Bentel, Jacqueline, McKay, Daniel, Conway, R. Max, Pereira, Michelle R., Mirzai, Bob, Calapre, Leslie, Erber, Wendy N., Ziman, Melanie R., Gray, Elin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657240/ https://www.ncbi.nlm.nih.gov/pubmed/34885099 http://dx.doi.org/10.3390/cancers13235990 |
Ejemplares similares
-
Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
por: Beasley, Aaron, et al.
Publicado: (2018) -
Detection of metastases using circulating tumour DNA in uveal melanoma
por: Beasley, Aaron B., et al.
Publicado: (2023) -
Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients
por: Asante, Du-Bois, et al.
Publicado: (2023) -
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
por: McEvoy, Ashleigh C., et al.
Publicado: (2018) -
Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression
por: Warburton, Lydia, et al.
Publicado: (2020)